A clinician examines a computer screen with an X-ray of bones.

ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in August.

September 6, 2023

ARUP Consult Updates Testing Resources for Osteoporosis, Immunobullous Diseases, and Epilepsy

ARUP Consult, a free source of expert guidance in laboratory testing, has released updated

A clinician holds up an X-ray.

ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in July.

August 2, 2023

ARUP Consult Updates Lyme Disease, Pneumonia, and Infertility Testing Resources

ARUP Consult, a free source of expert guidance in laboratory testing, has released updated

HPV test sample

ARUP Consult®, a free source of laboratory testing information for clinicians, has updated several resources in June.

July 6, 2023

ARUP Consult Updates Human Papillomavirus, Chronic Lymphocytic Leukemia, and Amenorrhea Resources

ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on

AAV5 DetectCDx™

ARUP’s new test is the first companion diagnostic immunoassay for a gene therapy product to receive FDA approval. FDA has issued simultaneous approval of ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), BioMarin’s gene therapy for severe hemophilia A.

June 29, 2023

FDA Approves ARUP Laboratories’ AAV5 DetectCDx™, a First-Ever Companion Diagnostic Immunoassay for a Gene…

ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay,

Valerie Collier

ARUP Laboratories’ Access and Reimbursement Manager Valerie Collier, MS, CGC, will be featured as an expert panelist in a special upcoming Dark Report webinar on June 29.

June 23, 2023

ARUP Expert to Present Insights on Obtaining Z-Codes in Special Dark Report…

Valerie Collier, MS, CGC, will present insights on the DEX MolDx program and how to submit

Tracy I. George sits at her desk

ARUP President and Chief Scientific Officer Tracy I. George, MD, pioneered the central pathology review service that screens and confirms potential patient candidates for clinical trials and monitors their drug responses.

June 12, 2023

ARUP’s Clinical Trials Support Leads to First FDA-Approved Drug for Indolent Systemic…

ARUP’s Clinical Trials and PharmaDx groups supported Blueprint Medicines’ clinical trials